HopeStage
Back to all studies
CompletedNCT03573297

Cariprazine to Prevent Relapse in Bipolarity With Mania or Depression

About this title

A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

Read the official source — NCT03573297
Medication studyAges 18–65Multiple countries
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Little Rock and 107 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: June 15, 2018
Recruitment status
Completed
Enrollment listed in the registry
901
Sponsor
AbbVie
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Bulgaria, Malaysia, ...
Age range
From 18 Years to 65 Years
Official registry ID
NCT03573297
Official title
Show the full official title

A Double-blind, Placebo-controlled, Randomized Withdrawal, Multicenter Clinical Trial Evaluating the Efficacy, Safety and Tolerability of Cariprazine in a Dose-reduction Paradigm in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Little Rock, United States · Rogers, United States · Anaheim, United States

89 more locations
  • Bellflower, United States
  • Cerritos, United States
  • Costa Mesa, United States
  • Culver City, United States
  • Garden Grove, United States
  • Glendale, United States
  • La Habra, United States
  • Lemon Grove, United States
  • Long Beach, United States
  • Orange, United States
  • San Diego, United States
  • San Marcos, United States
  • Torrance, United States
  • Colorado Springs, United States
  • Hallandale, United States
  • Hollywood, United States
  • Jacksonville, United States
  • Maitland, United States
  • Miami Lakes, United States
  • Tampa, United States
  • Atlanta, United States
  • Decatur, United States
  • Dunwoody, United States
  • Winfield, United States
  • Shreveport, United States
  • Gaithersburg, United States
  • Saint Charles, United States
  • Las Vegas, United States
  • Berlin, United States
  • Cedarhurst, United States
  • Charlotte, United States
  • Raleigh, United States
  • Beavercreek, United States
  • Columbus, United States
  • Dayton, United States
  • Oklahoma City, United States
  • Austin, United States
  • Richardson, United States
  • The Woodlands, United States
  • Burgas, Bulgaria
  • Kardzhali, Bulgaria
  • Kazanlak, Bulgaria
  • Lovech, Bulgaria
  • Pleven, Bulgaria
  • Rousse, Bulgaria
  • Sofia, Bulgaria
  • Targovishte, Bulgaria
  • Ipoh, Malaysia
  • Kuala Lumpur, Malaysia
  • Lublin, Poland
  • Gdansk, Poland
  • Poznan, Poland
  • Chełmno, Poland
  • San Juan, Puerto Rico
  • Kazan', Russia
  • Moscow, Russia
  • Nizhny Novgorod, Russia
  • Orenburg, Russia
  • Roschino, Russia
  • Saint Petersburg, Russia
  • Saratov, Russia
  • Tomsk, Russia
  • Tonnelniy, Russia
  • Belgrade, Serbia
  • Kragujevac, Serbia
  • Novi Sad, Serbia
  • Kovin, Serbia
  • Novi Kneževac, Serbia
  • Busan, South Korea
  • Gwangju, South Korea
  • Jeju City, South Korea
  • Jeonju, South Korea
  • Taipei City, Taiwan
  • New Taipei City, Taiwan
  • Taichung, Taiwan
  • Tainan, Taiwan
  • Taipei, Taiwan
  • Chiang Mai, Thailand
  • Muang, Thailand
  • Smila, Ukraine
  • Kryvbas Village, Ukraine
  • Kharkiv, Ukraine
  • Stepanivka Village, Ukraine
  • Oleksandrivka Village, Ukraine
  • Uzhhorod, Ukraine
  • Lviv, Ukraine
  • Odesa, Ukraine
  • Vinnytsia, Ukraine
  • Russia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is AbbVie.

Did this study involve medication?

Yes. The study involved medication, including Cariprazine and Placebo.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies